IL-6 levels also correlate to increased number of MDSCs, tumor-associated neutrophils (TANs), regulatory T cells (Tregs) in many cancers including breast cancer, suggesting that the consequent immune-suppressive environment contributes to cancer evasion [114]. The gene discussed is IL6; the disease is breast cancer.